Picks

China’s extraordinary rise in science and how it will change the world

Jazz CEO calls on industry to help rebuild momentum for leadership diversity

European biotech leaders split on US-China fight for deal dominance, survey finds

Alnylam bulls and bears fight it out after business-shaking guidance cut

FDA approves first drug to improve functional capacity and symptoms in children with rare inherited heart condition

最新进展10月14日 12:53玛伐凯泰拟纳入中国优先审评

Citron kinase activity controls alternative splicing events that drive prostate cancer growth.

Catabolism of extracellular glutathione is a driver of metastasis formation

Glyceraldehyde-3-phosphate sensing by SOS1 and RAS sustains a self-reinforcing oncogenic metabolic-signaling circuit

Another Paragon spinout goes public through reverse merger

STAT+: BlackRock to buy majority stake in Humana’s CenterWell clinics for $2.8 billion

康方依沃西一线晚期肺癌头对头 K 药 总生存期 30.8 个月对 22.6 个月

Cold and Room-Temperature Platelets in Cardiac Surgery

Tucidinostat Plus R-CHOP for Large B-Cell Lymphoma

From Biological Insight to a New Class of Medicines for Hemophilia A

The 2026 Albert Lasker Basic Medical Research Award

Error in Results

Updated Stroke Guideline Emphasizes Early, Holistic Intervention

FDA Approves 2 New Alzheimer Disease Blood Tests

Hanlim Pharm Co., Ltd. - 734782 - 10/02/2026

BioNTech BNT113联合帕博利珠单抗AHEAD-MERIT 2/3期首批顶线未达PFS主要终点